Voyager Therapeutics, Inc.

NASDAQ (USD): Voyager Therapeutics, Inc. (VYGR)

Last Price

6.22

Today's Change

-0.47 (7.02%)

Day's Change

6.18 - 6.77

Trading Volume

687,963

Overview

Market Cap

339 Million

Shares Outstanding

54 Million

Avg Volume

551,585

Avg Price (50 Days)

6.63

Avg Price (200 Days)

7.83

PE Ratio

23.04

EPS

0.27

Earnings Announcement

12-Nov-2024

Previous Close

6.69

Open

6.73

Day's Range

6.18 - 6.775

Year Range

5.71 - 11.72

Trading Volume

687,963

Price Change Highlight

1 Day Change

-7.03%

5 Day Change

-12.15%

1 Month Change

-15.49%

3 Month Change

-3.86%

6 Month Change

-26.65%

Ytd Change

-30.89%

1 Year Change

-8.12%

3 Year Change

81.87%

5 Year Change

-52.45%

10 Year Change

-64.96%

Max Change

-64.96%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy. The company has collaboration and license agreements with Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment